dpp4 and glp 1 mechanism of action Dipeptidyl Peptidase 4 Inhibitors in Antidiabetic Treatment Mechanism of action of DPP-4

Future Perspectives of GLP-1 RA Use in People with T2D People with T2D are at higher risk of CV events compared with those without T2D, and CV disease is the major cause of death in people with T2D [97]

Cabo J, Gelikman DG, Hsi RS (2023) The financial burden of nephrolithiasis and predictors of diseasespecific financial toxicity

Stable gastric pentadecapeptide BPC 157: novel mediator of Roberts cytoprotection and adaptive cytoprotection. Current Pharmaceutical Design, 20(7), 11261135

In this Review, we discuss common reasons for GLP1R agonist and tirzepatide discontinuation and examine available evidence related to potential cardiometabolic consequences